Patent · US Active

Epitopes from allergen proteins and methods and uses for immune response modulation

US10918713B2 · kind B2 · utility

0Cited by
5References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 23, 2017
Grant dateFeb 16, 2021
Priority date
Expiry dateAug 23, 2037

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/24
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to common allergen proteins and peptides, subsequences, portions, homologues, variants and derivatives thereof, and methods and uses of common allergen proteins and peptides. Methods include, for example, modulating an immune response; protecting a subject against or treating a subject for an allergic response, allergic disorder or allergic disease; and inducing immunological tolerance to the allergen in a subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.